Cargando…
Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
PURPOSE: To assess the effectiveness and safety of intravitreal aflibercept in clinically significant diabetic macular edema (DME) in daily clinical practice. METHODS: Prospective, open-label, single-center study. Anti-vascular endothelial growth factor naïve patients with clinically significant DME...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764298/ https://www.ncbi.nlm.nih.gov/pubmed/29386883 http://dx.doi.org/10.2147/OPTH.S154421 |